Company Information
- Type:
- Company
- Country:
- Switzerland
- Sector:
- Pharmaceuticals & Biotechnology
- Ownership:
- Privately Held
- Global Compact Status:
- Active
- Participant Since
- 08 January 2024 Letter of Commitment
- Next Communication on Progress (COP) due on:
- 31 July 2025
Parent Company
| Country | Company Name |
|---|---|
| Japan | Takeda Pharmaceutical Company Limited |
Parent Communication On Progress
| Published On | Title | Level/Status |
|---|---|---|
| 23-Jul-2024 | 2024 Communication on Progress | Submitted |
| 16-Dec-2022 | 2022 Annual Integrated Report | Active |
| 20-Dec-2021 | 2021 Annual Integrated Report | Learner |
| 25-Dec-2020 | 2020 Sustainability Report | Active |
| 14-Jan-2020 | Sustainable Value Report 2019 | Active |
| 31-Jul-2019 | Grace Letter | Not applicable |
| 30-Oct-2018 | Sustainable Value Report 2018 | Advanced |
| 30-Oct-2017 | Sustainable Value Report 2017 | Advanced |
| 31-Oct-2016 | Communication on Progress | Advanced |
| 02-Nov-2015 | Communication on Progress | Advanced |
| 04-Nov-2014 | Communication on Progress | Advanced |
| 10-Nov-2013 | Communication on Progress | Advanced |
| 09-Nov-2012 | Communication on Progress | Advanced |
| 08-Dec-2011 | Annual Report 2011/ CSR Databook 2011 | Advanced |
| 08-Dec-2010 | 2010 Communication on Progress | Not applicable |
| 08-Dec-2009 | 2009 CSR Databook | Not applicable |